1. Small Jr W, Beriwal S, Demanes DJ et al. American Brachytherapy Society consensus guidelines for adjuvant vaginal cuff brachytherapy after hysterectomy. Brachytherapy 2012; 11: 58-67.
2.
Nag S, Erickson B, Parikh S et al. The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the endometrium. Int J Radiat Oncol Biol Phys 2000; 48: 779-790.
3.
Harkenrider MM, Block AM, Alektiar KM et al. American Brachytherapy Task Group Report: Adjuvant vaginal brachytherapy for early-stage endometrial cancer: A comprehensive review. Brachytherapy 2017; 16: 95-108.
4.
Harkenrider MM, Abu-Rustum N, Albuquerque K et al. Radiation therapy for endometrial cancer: an American Society for Radiation Oncology clinical practice guideline. Pract Radiat Oncol 2023; 13: 41-65.
5.
Morrison J, Balega J, Buckley L et al. British Gynaecological Cancer Society (BGCS) uterine cancer guidelines: Recommendations for practice. Eur J Obstet Gynecol Reprod Biol 2022; 270: 50-89.
6.
Kumar NP, Kumar A, Jayaprakash PG et al. Dosimetric comparison of bladder, rectal, and vaginal surface doses between ovoids and cylinder-based vaginal brachytherapy in carcinoma of the endometrium. J Cancer Res Ther 2018; 14: 1191-1195.
7.
Concin N, Matias-Guiu X, Vergote I et al. ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma. Int J Gynecol Cancer 2021; 31: 12-39.
8.
Sapienza LG, Ning MS, De La Pena R et al. Outcomes and toxicity after salvage radiotherapy for vaginal relapse of endometrial cancer. Int J Gynecol Cancer 2020; 30: 1535-1541.
9.
Rios-Doria E, Cun HT, Filippova OT et al. Isolated vaginal recurrence in women with stage I endometrial cancer. Gynecol Oncol 2023; 179: 9-15.
10.
Kim H, Rajagopalan MS, Houser C et al. Dosimetric comparison of multichannel with one single-channel vaginal cylinder for vaginal cancer treatments with high-dose-rate brachytherapy. Brachytherapy 2014; 13: 263-267.
11.
Demanes DJ, Rege S, Rodriquez RR et al. The use and advantages of a multichannel vaginal cylinder in high-dose-rate brachytherapy. Int J Radiat Oncol Biol Phys 1999; 44: 211-219.
12.
Biltekin F, Akyol H, Gultekin M et al. Intensity-modulated vaginal brachytherapy applicator and single-and multi-channel applicators in vaginal cuff brachytherapy. J Contemp Brachytherapy 2024; 16: 132-138.
13.
Bahadur YA, Constantinescu C, Hassouna AH et al. Single versus multichannel applicator in high-dose-rate vaginal brachytherapy optimized by inverse treatment planning. J Contemp Brachytherapy 2015; 6: 362-370.
14.
Carrara M, Cusumano D, Giandini T et al. Comparison of different treatment planning optimization methods for vaginal HDR brachytherapy with multichannel applicators: a reduction of the high doses to the vaginal mucosa is possible. Phys Med 2017; 44: 58-65.
15.
Vargo JA, Kim H, Houser CJ et al. Image-based multichannel vaginal cylinder brachytherapy for vaginal cancer. Brachytherapy 2015; 14: 9-15.
16.
Li S, Aref I, Walker E et al. Effects of prescription depth, cylinder size, treatment length, tip space, and curved end on doses in high-dose-rate vaginal brachytherapy. Int J Radiat Oncol Biol Phys 2007; 67: 1268-1277.
17.
Wang K, Jiang P, Wang J. Dosimetric evaluation of different cylinder diameters in three-dimensional vaginal brachytherapy for early-stage endometrial cancer. J Cancer Res Clin Oncol 2024; 150: 510.
18.
Hou X, Liu A, Zhang F et al. Dosimetric advantages of using multichannel balloons compared to single-channel cylinders for high-dose-rate vaginal cuff brachytherapy. Brachytherapy 2016; 15: 471-476.
19.
Tanderup K, Lindegaard JC. Multi-channel intracavitary vaginal brachytherapy using three-dimensional optimization of source geometry. Radiother Oncol 2004; 70: 81-85.
20.
Albuquerque K, Hrycushko BA, Harkenrider MM et al. Compendium of fractionation choices for gynecologic HDR brachytherapy – an American Brachytherapy Society Task Group Report. Brachytherapy 2019; 18: 429-436.
21.
Van Elburg D, Meyer T, Martell K, et al. Assessment of dose to vaginal mucosa for gynecologic template interstitial high-dose-rate brachytherapy using Monte Carlo simulation. J Contemp Brachytherapy 2023; 15: 317-324.
22.
Bahng AY, Dagan A, Bruner DW et al. Determination of prognostic factors for vaginal mucosal toxicity associated with intravaginal high-dose rate brachytherapy in patients with endometrial cancer. Int J Radiat Oncol Biol Phys 2012; 82: 667-673.
23.
Serban M, de Leeuw AA, Tanderup K et al. Vaginal dose-surface maps in cervical cancer brachytherapy: Methodology and preliminary results on correlation with morbidity. Brachytherapy 2021; 20: 565-575.
24.
Susko M, Craciunescu O, Meltsner S et al. Vaginal dose is associated with toxicity in image guided tandem ring or ovoid-based brachytherapy. Int J Radiat Oncol Biol Phys 2016; 94: 1099-1105.
25.
Zhang Y, Ascaso C, Herreros A et al. Postoperative endometrial carcinoma treated with external beam irradiation plus vaginal-cuff brachytherapy. Is there a dose relationship with G2 vaginal complications? Rep Pract Oncol Radiother 2020; 25: 227-232.
26.
Zhang Y, Gómez G, Ascaso C et al. Preliminary results of a vaginal constraint for reducing G2 late vaginal complications after postoperative brachytherapy in endometrial cancer: a prospective analysis. Clin Transl Oncol 2022; 24: 875-881.
27.
Rovirosa A, Noorian F, Cordoba S et al. Where are we with fractionation schedules and prescriptions in high-dose-rate 3D planning vaginal cuff brachytherapy? J Contemp Brachytherapy 2024; 16: 352-361.
28.
Mao Z, Zhao H. 3D-printed vaginal cylindrical template with curved needle channels in MRI-guided vaginal cuff brachytherapy. J Contemp Brachytherapy 2023; 15: 422-431.
